123: Lenacapavir for HIV Prevention
from Febrile
Drs. Anshel Kenkare and Mike Reid share a conversation about the incredible science and current context of lenacapavir for HIV prevention, which was recently approved by the FDA. Episodes | Consult Notes | Subscribe | Twitter | Merch | [email protected] Febrile is produced with support from the Infectious Diseases Society of America (IDSA)
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Febrile?
This episode is 34 minutes long.
When was this Febrile episode published?
This episode was published on July 7, 2025.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this Febrile episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.